Bayer | Crop Science’s Post

📰 📰 ⚡ The news is out! 📰 📰 ⚡ I am officially a part of the Vector family. On top of those highlighted skills in Jack Shute's post, I thought I'd share a bit more here: 👩🔬 - I am a BIG nerd, I love research articles, video games, board games, and will absolutely want to fully understand what YOU do in your cool science jobs. 🦕 - I am a proud neurodiverse millennial, and truly believe my ADHD has made me great at my job (most of the time), as science is my "special interest", but I will absolutely fight for equality, and advocate for safe spaces in all of my client / candidate interactions. 🐱 🐶 - I love my pets, and all animals, and fundraise for animals out in desperately bad welfare countries like the UAE, or those caught in the current affairs of Gaza. So if you see any of these posts in the future, please support me in helping the voiceless! 🏃♀️ - Following having a lobectomy in 2019, I am relearning how to run! I've followed and failed the C25K a couple of times, but I am a big believer in picking yourself up, and I am proud to say I am now back on track for a fastish 5km soon! I'd appreciate any running tips, or parkrun buddies in the Manchester area. 🔭 🌏 - I am a Geophysicist by background, and spent time making python programmes, and hiking up volcanoes to "observe" them, but I am also obsessed with space, and the stars, and in another smarter life I would have absolutely become an astrophysicist. There is plenty more to come, but I'll leave it at that! Please follow, and connect with me to follow this journey - I will be looking to expand my network further into the CDMO/ CRO / Pharmaceutical space, and grow this platform. For those who haven't seen my other post - Vector provide a solution that meshes together an amazing talent acquisition / recruitment process training platform with a true business partner approach to executive recruitment. I can't wait to see what we achieve with these powerful tools - Thanks for having me Neil Kelly, Marianne G. and Jack Shute #businessgrowth #pharmaceutical #neurodiverse #Executivesearch

Thoughts on this? >> Controversies and pitfalls at ASCO24 >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharmaceutical #pharma #biotech #healthcare #competitivemarketing

Have you had enough of the subpar results you keep getting time after time cultivating cannabis? i know what it feels like but that can all change when you have the correct knowledge. Higher Heights Technique is a premium cultivation manual, designed for you to grow triple A top shelf high quality cannabis, guaranteed or your money back. Email, dm or click the link in our bio, lets get started today working together to change your cultivation experience to a positive one. #cannabis #cannabisindustry #cannabiscommunity #cannabisculture #cannabiseducation #cannabiscultivation #fourtwenty #marijuana #marijuanaindustry

What better way to celebrate #OpenScienceWeek than by registering for our CACHE 2 Participant Spotlight webinar! But you'll have to be quick because it's tomorrow, Wednesday September 18 at 1pm EDT. The two featured teams used very different methods, including using AI and citizen science, to make top-scoring predictions of what small molecules bind to the RNA-binding site on the NSP13 helicase of the COVID virus. This site is highly conserved, so an antiviral developed from these molecules could be a powerful tool against all coronaviruses. Those predictions, and the experimental data validating them as hits, are all shared openly because we want to empower everyone to be prepared for any future pandemics. Find out more, and the registration link, in the post below. Hope to see you there!

Curious about industry-academia partnerships? Daniel Bradbury, former CEO of Amylin Pharmaceuticals, shares his insights on collaborating with KGI's Team Master's Project (TMP). Our TMP offers life science companies a unique opportunity to drive innovation and tackle real-world challenges. In this video, Bradbury discusses: ❇️ Exploring new product forms and manufacturing processes ❇️ Working with interdisciplinary student teams ❇️ Cost-effective innovation in life sciences ❇️ Long-term impact on company initiatives "The value that [the students] have created in such a short period of time is tremendous," says Bradbury. Watch to learn how one TMP led to a new product development team at Amylin: https://kgi.link/xvu #LifeSciences #Innovation #KeckGrad #Testimonials

We asked sabina halappanavar, from Health Canada | Santé Canada, what motivated her to accept the invitation from HARMLESS to become a member of the Advisory Board. Listen to her here: https://lnkd.in/dgXCwqjw #NAM #toxicology #toxicitytesting #toxicityprediction #nanomaterials #advancedmaterials

Another course to deep dive into the Drug hunting process, to understand this process more closely as there are so many factors influencing the process of drug discovery/hunting. This course comes from one of the prominent pharmaceutical manufacturer and innovation driven company Novartis and the course basically summarizes the different steps of pre-clinical drug discovery, unmet medical needs, optimising lead selection and the importance of competitive intelligence giving me another perspective of this whole process.

🎙 This week on "The Top Line," we're diving into the details of the spree of big-money biopharma deals in 2023 and examining what that means for this year.

I am excited to share that I have completed the course on “Introduction to Drug Hunting” by Novartis and Davidson College on Coursera. Looking forward to gain more valuable insights in the world of Drug Discovery. #Novartis #pharmaceuticals #DrugHunting #careergrowth #coursera #DavidsonCollege

@Catailyst, Inc. Trending Topics: Sangamo Therapeutics, Inc. Therapeutics Announces Alignment With FDA on Accelerated Approval Pathway for ST-920 in #Fabry Disease With BLA Submission Expected in 2025 https://lnkd.in/d-HxtncX FDA confirms that estimated glomerular filtration rate (eGFR) slope data at one year across all Phase 1/2 patients can serve as primary basis for approval under Accelerated Approval pathway #Timeline Data supporting Accelerated Approval pathway available in first half of 2025 BLA submission expected in the second half of 2025. #Healthcare #FDA #Biotechnology #Fabry